+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Regenerative Medicine Market in Japan 2025-2029

  • PDF Icon

    Report

  • 167 Pages
  • February 2025
  • Region: Japan
  • TechNavio
  • ID: 5880852
1h Free Analyst Time

Increasing Number of Clinical Trials is a Key Trend Gaining Market Momentum

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The regenerative medicine market in Japan is forecasted to grow by USD 4.60 billion during 2024-2029, accelerating at a CAGR of 21.2% during the forecast period. The report on the regenerative medicine market in Japan provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of STEM cell therapy, rising prevalence of chronic diseases, and increasing aging population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The regenerative medicine market in Japan is segmented as below:

By Application

  • Oncology
  • Musculoskeletal
  • Dermatology
  • Others

By Technology

  • Cell and tissue-based
  • Gene therapy

By End-user

  • Hospitals and clinics
  • Speciality centers
  • Government and research institutes

By Geographical Landscape

  • APAC
This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicine market in Japan growth during the next few years. Also, growing mergers and acquisitions among companies and development of induced pluripotent STEM cells will lead to sizable demand in the market.

The report on the regenerative medicine market in Japan covers the following areas:

  • Regenerative Medicine Market in Japan sizing
  • Regenerative Medicine Market in Japan forecast
  • Regenerative Medicine Market in Japan industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicine market in Japan vendors that include Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., Nikon Corp., ROHTO Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp. Also, the regenerative medicine market in Japan analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan: Year-over-year growth 2024-2029 (%)
Data Table on Japan: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Regenerative Medicine Market in Japan 2019 - 2023
Historic Market Size - Data Table on Regenerative Medicine Market in Japan 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 Technology segment analysis 2019 - 2023
Historic Market Size - Technology Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Regenerative Medicine Market in Japan
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
8.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
8.4 Musculoskeletal - Market size and forecast 2024-2029
Chart on Musculoskeletal - Market size and forecast 2024-2029 ($ million)
Data Table on Musculoskeletal - Market size and forecast 2024-2029 ($ million)
Chart on Musculoskeletal - Year-over-year growth 2024-2029 (%)
Data Table on Musculoskeletal - Year-over-year growth 2024-2029 (%)
8.5 Dermatology - Market size and forecast 2024-2029
Chart on Dermatology - Market size and forecast 2024-2029 ($ million)
Data Table on Dermatology - Market size and forecast 2024-2029 ($ million)
Chart on Dermatology - Year-over-year growth 2024-2029 (%)
Data Table on Dermatology - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Technology
9.1 Market segments
Chart on Technology - Market share 2024-2029 (%)
Data Table on Technology - Market share 2024-2029 (%)
9.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
9.3 Cell and tissue-based - Market size and forecast 2024-2029
Chart on Cell and tissue-based - Market size and forecast 2024-2029 ($ million)
Data Table on Cell and tissue-based - Market size and forecast 2024-2029 ($ million)
Chart on Cell and tissue-based - Year-over-year growth 2024-2029 (%)
Data Table on Cell and tissue-based - Year-over-year growth 2024-2029 (%)
9.4 Gene therapy - Market size and forecast 2024-2029
Chart on Gene therapy - Market size and forecast 2024-2029 ($ million)
Data Table on Gene therapy - Market size and forecast 2024-2029 ($ million)
Chart on Gene therapy - Year-over-year growth 2024-2029 (%)
Data Table on Gene therapy - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Technology
Market opportunity by Technology ($ million)
Data Table on Market opportunity by Technology ($ million)
10 Market Segmentation by End-user
10.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Hospitals and clinics - Market size and forecast 2024-2029
Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
10.4 Speciality centers - Market size and forecast 2024-2029
Chart on Speciality centers - Market size and forecast 2024-2029 ($ million)
Data Table on Speciality centers - Market size and forecast 2024-2029 ($ million)
Chart on Speciality centers - Year-over-year growth 2024-2029 (%)
Data Table on Speciality centers - Year-over-year growth 2024-2029 (%)
10.5 Government and research institutes - Market size and forecast 2024-2029
Chart on Government and research institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Government and research institutes - Market size and forecast 2024-2029 ($ million)
Chart on Government and research institutes - Year-over-year growth 2024-2029 (%)
Data Table on Government and research institutes - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product/Service
Astellas Pharma Inc. - Key offerings
SWOT
14.5 Becton Dickinson and Co.
Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
SWOT
14.6 CellSeed Inc.
CellSeed Inc. - Overview
CellSeed Inc. - Product/Service
CellSeed Inc. - Key offerings
SWOT
14.7 Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K. - Overview
Cyfuse Biomedical K.K. - Product/Service
Cyfuse Biomedical K.K. - Key offerings
SWOT
14.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
14.9 FUJIFILM Holdings Corp.
FUJIFILM Holdings Corp. - Overview
FUJIFILM Holdings Corp. - Business segments
FUJIFILM Holdings Corp. - Key news
FUJIFILM Holdings Corp. - Key offerings
FUJIFILM Holdings Corp. - Segment focus
SWOT
14.10 iHeart Japan Corp.
iHeart Japan Corp. - Overview
iHeart Japan Corp. - Product/Service
iHeart Japan Corp. - Key offerings
SWOT
14.11 JCR Pharmaceticals Co. Ltd.
JCR Pharmaceticals Co. Ltd. - Overview
JCR Pharmaceticals Co. Ltd. - Product/Service
JCR Pharmaceticals Co. Ltd. - Key offerings
SWOT
14.12 Nikon Corp.
Nikon Corp. - Overview
Nikon Corp. - Business segments
Nikon Corp. - Key offerings
Nikon Corp. - Segment focus
SWOT
14.13 ROHTO Pharmaceutical Co. Ltd.
ROHTO Pharmaceutical Co. Ltd. - Overview
ROHTO Pharmaceutical Co. Ltd. - Business segments
ROHTO Pharmaceutical Co. Ltd. - Key offerings
ROHTO Pharmaceutical Co. Ltd. - Segment focus
SWOT
14.14 Sumitomo Pharma Co. Ltd.
Sumitomo Pharma Co. Ltd. - Overview
Sumitomo Pharma Co. Ltd. - Business segments
Sumitomo Pharma Co. Ltd. - Key offerings
Sumitomo Pharma Co. Ltd. - Segment focus
SWOT
14.15 Takara Bio Inc.
Takara Bio Inc. - Overview
Takara Bio Inc. - Product/Service
Takara Bio Inc. - Key news
Takara Bio Inc. - Key offerings
SWOT
14.16 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product/Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
14.17 Terumo Corp.
Terumo Corp. - Overview
Terumo Corp. - Business segments
Terumo Corp. - Key news
Terumo Corp. - Key offerings
Terumo Corp. - Segment focus
SWOT
14.18 Yokogawa Electric Corp.
Yokogawa Electric Corp. - Overview
Yokogawa Electric Corp. - Business segments
Yokogawa Electric Corp. - Key news
Yokogawa Electric Corp. - Key offerings
Yokogawa Electric Corp. - Segment focus
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Application
Exhibits 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Company Market Positioning
Exhibits 8: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 9: Overview on criticality of inputs and factors of differentiation
Exhibits 10: Overview on factors of disruption
Exhibits 11: Impact of drivers and challenges in 2024 and 2029
Exhibits 12: Parent Market
Exhibits 13: Data Table on - Parent Market
Exhibits 14: Market characteristics analysis
Exhibits 15: Value chain analysis
Exhibits 16: Offerings of companies included in the market definition
Exhibits 17: Market segments
Exhibits 18: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 19: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 20: Chart on Japan: Year-over-year growth 2024-2029 (%)
Exhibits 21: Data Table on Japan: Year-over-year growth 2024-2029 (%)
Exhibits 22: Historic Market Size - Data Table on Regenerative Medicine Market in Japan 2019 - 2023 ($ million)
Exhibits 23: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits 24: Historic Market Size - Technology Segment 2019 - 2023 ($ million)
Exhibits 25: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 26: Five forces analysis - Comparison between 2024 and 2029
Exhibits 27: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 28: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 29: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 30: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 31: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 32: Chart on Market condition - Five forces 2024 and 2029
Exhibits 33: Chart on Application - Market share 2024-2029 (%)
Exhibits 34: Data Table on Application - Market share 2024-2029 (%)
Exhibits 35: Chart on Comparison by Application
Exhibits 36: Data Table on Comparison by Application
Exhibits 37: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 38: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 39: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 40: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 41: Chart on Musculoskeletal - Market size and forecast 2024-2029 ($ million)
Exhibits 42: Data Table on Musculoskeletal - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Chart on Musculoskeletal - Year-over-year growth 2024-2029 (%)
Exhibits 44: Data Table on Musculoskeletal - Year-over-year growth 2024-2029 (%)
Exhibits 45: Chart on Dermatology - Market size and forecast 2024-2029 ($ million)
Exhibits 46: Data Table on Dermatology - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Chart on Dermatology - Year-over-year growth 2024-2029 (%)
Exhibits 48: Data Table on Dermatology - Year-over-year growth 2024-2029 (%)
Exhibits 49: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 50: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 52: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 53: Market opportunity by Application ($ million)
Exhibits 54: Data Table on Market opportunity by Application ($ million)
Exhibits 55: Chart on Technology - Market share 2024-2029 (%)
Exhibits 56: Data Table on Technology - Market share 2024-2029 (%)
Exhibits 57: Chart on Comparison by Technology
Exhibits 58: Data Table on Comparison by Technology
Exhibits 59: Chart on Cell and tissue-based - Market size and forecast 2024-2029 ($ million)
Exhibits 60: Data Table on Cell and tissue-based - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Chart on Cell and tissue-based - Year-over-year growth 2024-2029 (%)
Exhibits 62: Data Table on Cell and tissue-based - Year-over-year growth 2024-2029 (%)
Exhibits 63: Chart on Gene therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 64: Data Table on Gene therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Chart on Gene therapy - Year-over-year growth 2024-2029 (%)
Exhibits 66: Data Table on Gene therapy - Year-over-year growth 2024-2029 (%)
Exhibits 67: Market opportunity by Technology ($ million)
Exhibits 68: Data Table on Market opportunity by Technology ($ million)
Exhibits 69: Chart on End-user - Market share 2024-2029 (%)
Exhibits 70: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 71: Chart on Comparison by End-user
Exhibits 72: Data Table on Comparison by End-user
Exhibits 73: Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 74: Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Exhibits 76: Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Exhibits 77: Chart on Speciality centers - Market size and forecast 2024-2029 ($ million)
Exhibits 78: Data Table on Speciality centers - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Chart on Speciality centers - Year-over-year growth 2024-2029 (%)
Exhibits 80: Data Table on Speciality centers - Year-over-year growth 2024-2029 (%)
Exhibits 81: Chart on Government and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 82: Data Table on Government and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Chart on Government and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 84: Data Table on Government and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 85: Market opportunity by End-user ($ million)
Exhibits 86: Data Table on Market opportunity by End-user ($ million)
Exhibits 87: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 88: Impact of drivers and challenges in 2024 and 2029
Exhibits 89: Overview on criticality of inputs and factors of differentiation
Exhibits 90: Overview on factors of disruption
Exhibits 91: Impact of key risks on business
Exhibits 92: Companies covered
Exhibits 93: Company ranking index
Exhibits 94: Matrix on companies position and classification
Exhibits 95: Astellas Pharma Inc. - Overview
Exhibits 96: Astellas Pharma Inc. - Product/Service
Exhibits 97: Astellas Pharma Inc. - Key offerings
Exhibits 98: SWOT
Exhibits 99: Becton Dickinson and Co. - Overview
Exhibits 100: Becton Dickinson and Co. - Business segments
Exhibits 101: Becton Dickinson and Co. - Key news
Exhibits 102: Becton Dickinson and Co. - Key offerings
Exhibits 103: Becton Dickinson and Co. - Segment focus
Exhibits 104: SWOT
Exhibits 105: CellSeed Inc. - Overview
Exhibits 106: CellSeed Inc. - Product/Service
Exhibits 107: CellSeed Inc. - Key offerings
Exhibits 108: SWOT
Exhibits 109: Cyfuse Biomedical K.K. - Overview
Exhibits 110: Cyfuse Biomedical K.K. - Product/Service
Exhibits 111: Cyfuse Biomedical K.K. - Key offerings
Exhibits 112: SWOT
Exhibits 113: F. Hoffmann La Roche Ltd. - Overview
Exhibits 114: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 115: F. Hoffmann La Roche Ltd. - Key news
Exhibits 116: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 117: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 118: SWOT
Exhibits 119: FUJIFILM Holdings Corp. - Overview
Exhibits 120: FUJIFILM Holdings Corp. - Business segments
Exhibits 121: FUJIFILM Holdings Corp. - Key news
Exhibits 122: FUJIFILM Holdings Corp. - Key offerings
Exhibits 123: FUJIFILM Holdings Corp. - Segment focus
Exhibits 124: SWOT
Exhibits 125: iHeart Japan Corp. - Overview
Exhibits 126: iHeart Japan Corp. - Product/Service
Exhibits 127: iHeart Japan Corp. - Key offerings
Exhibits 128: SWOT
Exhibits 129: JCR Pharmaceticals Co. Ltd. - Overview
Exhibits 130: JCR Pharmaceticals Co. Ltd. - Product/Service
Exhibits 131: JCR Pharmaceticals Co. Ltd. - Key offerings
Exhibits 132: SWOT
Exhibits 133: Nikon Corp. - Overview
Exhibits 134: Nikon Corp. - Business segments
Exhibits 135: Nikon Corp. - Key offerings
Exhibits 136: Nikon Corp. - Segment focus
Exhibits 137: SWOT
Exhibits 138: ROHTO Pharmaceutical Co. Ltd. - Overview
Exhibits 139: ROHTO Pharmaceutical Co. Ltd. - Business segments
Exhibits 140: ROHTO Pharmaceutical Co. Ltd. - Key offerings
Exhibits 141: ROHTO Pharmaceutical Co. Ltd. - Segment focus
Exhibits 142: SWOT
Exhibits 143: Sumitomo Pharma Co. Ltd. - Overview
Exhibits 144: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits 145: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits 146: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits 147: SWOT
Exhibits 148: Takara Bio Inc. - Overview
Exhibits 149: Takara Bio Inc. - Product/Service
Exhibits 150: Takara Bio Inc. - Key news
Exhibits 151: Takara Bio Inc. - Key offerings
Exhibits 152: SWOT
Exhibits 153: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 154: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibits 155: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 156: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 157: SWOT
Exhibits 158: Terumo Corp. - Overview
Exhibits 159: Terumo Corp. - Business segments
Exhibits 160: Terumo Corp. - Key news
Exhibits 161: Terumo Corp. - Key offerings
Exhibits 162: Terumo Corp. - Segment focus
Exhibits 163: SWOT
Exhibits 164: Yokogawa Electric Corp. - Overview
Exhibits 165: Yokogawa Electric Corp. - Business segments
Exhibits 166: Yokogawa Electric Corp. - Key news
Exhibits 167: Yokogawa Electric Corp. - Key offerings
Exhibits 168: Yokogawa Electric Corp. - Segment focus
Exhibits 169: SWOT
Exhibits 170: Inclusions checklist
Exhibits 171: Exclusions checklist
Exhibits 172: Currency conversion rates for US$
Exhibits 173: Research methodology
Exhibits 174: Information sources
Exhibits 175: Data validation
Exhibits 176: Validation techniques employed for market sizing
Exhibits 177: Data synthesis
Exhibits 178: 360 degree market analysis
Exhibits 179: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the regenerative medicine market in japan: Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., Nikon Corp., ROHTO Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of clinical trials."

According to the report, one of the major drivers for this market is the increasing adoption of stem cell therapy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Astellas Pharma Inc.
  • Becton Dickinson and Co.
  • CellSeed Inc.
  • Cellusion Inc.
  • Cyfuse Biomedical K.K.
  • F. Hoffmann La Roche Ltd.
  • FUJIFILM Holdings Corp.
  • iHeart Japan Corp.
  • Japan Tissue Engineering Co. Ltd.
  • JCR Pharmaceticals Co. Ltd.
  • Nikon Corp.
  • ROHTO Pharmaceutical Co. Ltd.
  • Sumitomo Pharma Co. Ltd.
  • Takara Bio Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Terumo Corp.
  • Yokogawa Electric Corp.